Implementation and support of a consistent, responsive enterprise-wide container-based, virtualized DevOps solution that reduces costs while enhancing agility

Client Success Story | Implementation and support of a consistent, responsive enterprise-wide container based, virtualized DevOps solution that reduced costs while enhancing agility.


The Food & Drug Administration (FDA) is a federal agency with over 35,000 employees that are responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation’s food supply, cosmetics, and products that emit radiation. The FDA’s Office of Information Management and Technology (OIMT) wanted to modernize the enterprise-wide infrastructure and application delivery platforms while realizing significant savings in hardware resources, software licenses costs and in operations and maintenance costs. OIMT needed to reduce costs, and serve its FDA mission area customers with high IT responsiveness, while eliminating the environmental inconsistencies and providing an ecosystem for application portability and agility. FDA identified the Docker based Container as a Service (CaaS) solution to fit the needs of its IT infrastructure.


Arlluk implemented and supports the FDA’s Docker Container-as-a-Service (CaaS) virtualization solution. The immediate need was to document and stabilize the FDA enterprise infrastructure so that applications could be efficiently onboarded to the enterprise-wide CaaS environment. This simplifies the deployment process and results in fewer errors during application deployments and software stack installation. Docker technology allowed the FDA to modernize its enterprise infrastructure though the use of a leading edge open source container virtualization technology.


The FDA realized consistency among environments and maintenance of those environments by implementing this CaaS solution. This significantly reduced costs for FDA/OIMT by allowing considerably more containers than VMs per physical server. Furthermore, the infrastructure was modernized to be able to deploy applications faster and with fewer errors which increased customer satisfaction and adaptability. In moving to production, Arlluk conducted briefings to enterprise application development teams that introduced them to the CaaS environment and assisted them with migrating their applications into it.